跳至主要内容
临床试验/NCT03638349
NCT03638349已完成不适用

Actions & Insights Evaluating a Novel Diabetes Management Solution.

LifeScan Scotland Ltd3 个研究点 分布在 1 个国家目标入组 163 人开始时间: 2018年7月17日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
163
试验地点
3
主要终点
Scaled preference questionnaires on new blood glucose monitoring digital tool.

研究概览

简要总结

Single visit outcome study to obtain qualitative and quantitative data for a new BGMS.

详细描述

During ASCEND, patients will complete a single visit clinical study divided into two distinct parts. Part 1 involves each subject completing a number of simple quantitative exercises to gauge their level of comprehension of diabetes related information. Subjects will then continue during the same visit to complete part 2 which involves gathering qualitative feedback from each subject on the new Blood glucose monitoring system.

研究设计

研究类型
Observational
观察模型
Other
时间视角
Cross Sectional

入排标准

年龄范围
16 Years 至 —(Child, Adult, Older Adult)
性别
All
接受健康志愿者
否

入选标准

  • •Diagnosed with T1DM or T2DM
  • •Performs SMBG
  • •Male or female, at least 16 years old.
  • •Able to communicate (speak, read and write) in English
  • •Willing to sign an informed consent.

排除标准

  • •Unlikely to be compliant with the study in the opinion of study staff.
  • •Conflict of Interest - Prospective Participants are currently working for, previously worked for, or have an immediate family member currently working for a company that manufactures or markets the products tested under this procedure

结局指标

主要结局

Scaled preference questionnaires on new blood glucose monitoring digital tool.

时间窗: 1 hour

Proportion of positive responses from scaled response questionnaires, scaled from 1 to 6, 1 being the most negative response and 6 being the most positive.

次要结局

  • Scaled preference questionnaires on new blood glucose monitoring digital tool for Type 2 subjects.(1 hour)
  • Scaled preference questionnaires on new blood glucose monitoring digital tool for Type 1 subjects.(1 hour)
  • Scaled preference questionnaires on new blood glucose monitoring digital tool based on subject A1c.(1 hour)
  • Scaled preference questionnaires on new blood glucose monitoring digital tool based on subject subject numeracy.(1 hour)
  • Preference questionnaires on new blood glucose monitoring digital tool based on insulin or non-insulin using subjects(1 hour)

研究者

发起方
LifeScan Scotland Ltd
申办方类型
Industry
责任方
Sponsor

研究点 (3)

Loading locations...

相似试验